C. Haller et al., CARDIAC TROPONIN-T IN PATIENTS WITH END-STAGE RENAL-DISEASE - ABSENCEOF EXPRESSION IN TRUNCAL SKELETAL-MUSCLE, Clinical chemistry, 44(5), 1998, pp. 930-938
In patients with end-stage renal disease (ESRD), the serum concentrati
on of cardiac troponin T (cTnT) may be increased without cardiac ische
mia. One reason for this unexplained increase could be the extracardia
c expression of cTnT. However, truncal skeletal muscle biopsies of fiv
e patients with ESRD showed no evidence of the expression of either cT
nT mRNA (reverse transcription-PCR) or protein (immunoblot, immunofluo
rescence). We also measured the serum concentration of cTnT in 97 pati
ents with ESRD. The serum cTnT concentration determined in both first
and second generation cTnT assays was significantly lower P < 0.01 in
patients with a low cardiac risk than in patients with positive indica
tors of coronary artery disease. The correlation between cTnT and indi
cators of coronary artery disease is consistent with the hypothesis th
at cTnT in the serum of patients with ESRD originates from the heart.